Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2005;36:2619-2625
Published online before print October 27, 2005, doi: 10.1161/01.STR.0000189998.74892.24
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
36/12/2619    most recent
01.STR.0000189998.74892.24v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yong, M.
Right arrow Articles by Mau, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yong, M.
Right arrow Articles by Mau, J.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
*Stroke
Related Collections
Right arrow Acute Cerebral Infarction

(Stroke. 2005;36:2619.)
© 2005 American Heart Association, Inc.


Original Contributions

Characteristics of Blood Pressure Profiles as Predictors of Long-Term Outcome After Acute Ischemic Stroke

Mei Yong, MPH; Hans-Christoph Diener, MD; Markku Kaste, MD, PhD Jochen Mau, PhD

From the Department of Statistics in Medicine (M.Y., J.M.), Heinrich Heine University Duesseldorf, Germany; Department of Neurology (H.-C.D.), University of Duisburg-Essen, Essen, Germany; and Department of Neurology (M.K.), Helsinki University Central Hospital, Finland.

Correspondence to Mei Yong, MPH, Department of Statistics in Medicine, Heinrich Heine University Duesseldorf, University Street 1, PO Box 101007, D-40001 Duesseldorf, Germany. E-mail yong{at}uni-duesseldorf.de

Background and Purpose— Most patients have elevated blood pressure (BP) in the early phase after an acute ischemic stroke. Mechanism and effects of this BP elevation are not well understood. The benefits of intervention by lowering the initial BP or waiting for spontaneous return to normal values remain debated. We studied the hypothesis that increased BP level and profile variability will adversely affect long-term outcome after stroke with and without thrombolytic treatment.

Methods— We studied the 615 patients with acute ischemic hemispheric stroke in the first European Cooperative Acute Stroke Study (ECASS). BP was measured at 2-hour intervals during the first 20 hours after randomization, and then every 4 hours, up to 72 hours after admission. Studied features of individual 0- to 72-hour BP profiles were: baseline BP, maximum and minimum BP, mean level, and successive variation in the BP profile. The end point was good functional recovery (modified Rankin Scale [mRS] score of 0 to 1) at 90 days. Logistic regression was used to adjust for known prognostic factors, demographic, initial stroke severity, disease and medication histories, and computed tomography signs.

Results— Higher systolic BP or diastolic BP at baseline were associated with favorable outcome assessed on modified mRS at 90 days (adjusted odds ratio [OR], 1.22; 95% CI, 1.01 to 1.49; and OR, 1.22; 95% CI, 1.01 to 1.49 per 10 mm Hg), lower within-patient 0- to 72-hour average systolic BP (SBP), or DBP implied favorable outcome (OR, 0.74; 95% CI, 0.61 to 0.90; and OR, 0.61; 95% CI, 0.41 to 0.90 per 10 mm Hg). Reduced variability of 0- to 72-hour DBP profile was an independent predictor of favorable outcome (OR, 0.58; 95% CI, 0.39 to 0.85 per 5 mm Hg).

Conclusions— Higher baseline SBP or DBP was associated with favorable outcome after stroke. Other characteristics of first 72-hour BP profiles: lower mean level of SBP or DBP and reduced successive variability of DBP profile were independent predictors of favorable outcome at 90 days.


Key Words: blood pressure • outcome • stroke, ischemic • tissue plasminogen activator




This article has been cited by other articles:


Home page
NEJMHome page
S. Yusuf, H.-C. Diener, R. L. Sacco, D. Cotton, S. Ounpuu, W. A. Lawton, Y. Palesch, R. H. Martin, G. W. Albers, P. Bath, et al.
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
N. Engl. J. Med., August 27, 2008; (2008) NEJMoa0804593v1.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
H.-C. Diener, K. R. Lees, P. Lyden, J. Grotta, A. Davalos, S. M. Davis, A. Shuaib, T. Ashwood, W. Wasiewski, V. Alderfer, et al.
NXY-059 for the Treatment of Acute Stroke: Pooled Analysis of the SAINT I and II Trials
Stroke, June 1, 2008; 39(6): 1751 - 1758.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Yong and M. Kaste
Association of Characteristics of Blood Pressure Profiles and Stroke Outcomes in the ECASS-II Trial
Stroke, February 1, 2008; 39(2): 366 - 372.
[Abstract] [Full Text] [PDF]